Can the hair-loss drug finasteride affect mental health?

Prof Nial Wheate

writer

Prof Nial Wheate

Professor, School of Natural Sciences, Macquarie University

Jasmine Lee

writer

Jasmine Lee

For many men the gradual thinning of hair is about more than just their appearance. Finasteride, a drug widely prescribed for the treatment of male pattern baldness has been used effectively for many years for this deeply personal problem.

Yet, behind its use are growing concerns about its link to the development of depression, anxiety, and even suicidal thoughts.

There is now critical discussion among both users and health-care professionals about the potential hazards associated with its continued use.

So how does the drug work? And what does the evidence say about the risk of developing a mental health problem?

How does finasteride work?

Finasteride is used to treat androgenetic alopecia, also known as male pattern baldness. It works to regrow hair and prevent the further loss of hair.

One of the key causes of pattern baldness is the production of a hormone called dihydrotestosterone which the body makes from testosterone. When it binds to the follicles of hairs, it initiates a process called hair follicle miniaturisation. This is where the growth cycle of the hair becomes progressively shorter, resulting in thinner and weaker hair.

Finasteride works by blocking the enzyme that converts testosterone to dihydrotestosterone. By blocking the enzyme, dihydrotestosterone concentrations can be reduced by around 60–70% for the majority of men.

Finasteride was first approved in the late 1990s as a prescription-only medicine and is taken as a daily 1 milligram oral tablet. Medications available at a higher 5 mg daily dose are not used for baldness, but as a treatment for non-cancerous prostate enlargement.

This medication is not indicated for women, even though they can also have this type of hair loss.

How can it impact mental health?

Changes in mental health are not listed as an established side effect in Australian guidance given to health-care professionals.

Based on clinical trials, the most common effects include:

  • decreased libido
  • erectile dysfunction
  • reduced semen production.

The guidance also describes an increased risk of prostate cancer and a potential risk for breast cancer. Yes, men can get breast cancer too.

While initial clinical trials conducted to obtain approval for the drug didn’t demonstrate mental health concerns, monitoring of patients using the drug has since indicated a potential increased risk of depression and suicidal thoughts. But as this is based on patients self-reporting symptoms, according to the guidance there is no definitive link.

However, in May 2025, the European Medicines Agency safety committee stated suicidal thoughts was a confirmed side effect of finasteride. The European Union also advises patients that finasteride can cause a depressed mood and depression.

Similarly, in a warning about compounded finasteride, the United States Food and Drug Administration stated in April 2025 that topical formulations of the drug has similar side effects to the oral version. These include depression, anxiety and suicidal thoughts.

Options for people who are concerned the drug may be impacting their mental health?

Patients with mild symptoms may pause finasteride to see whether things improve, or try continuing with additional mental health support. If symptoms are more severe, stopping the medication and getting prompt medical review may be appropriate.

For those taking the drug who are concerned about side effects, it is safe to stop immediately. Most side effects ease once the medication is out of their system, although a small number of people have reported symptoms that persist.

When someone stops the drug, their hormone levels will gradually return to baseline and the hair growth seen with the drug will be lost over time.

If finasteride is not the right fit, there is another evidence-based alternative.

Topical minoxidil is a first-line treatment that can be used on its own or with other treatments and is available from pharmacies over the counter. It only works while it’s being used and may irritate the scalp, but its effectiveness is well-established and widely recommended.

While depression and anxiety are associated with minoxidil, the incidence is much lower because of their topical application.

There is also a medication called dutasteride. However, as it works in a similar way to finasteride, it may also increase the risk of developing mental health problems. So it is best to avoid dutasteride if finasteride is not suitable.


If this story has raised any issues for you, please contact one of the services below:

Nial Wheate, Professor, School of Natural Sciences, Macquarie University and Jasmine Lee, Pharmacist and PhD Candidate, University of Sydney

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Philip Tong

Dr Philip Tong

Facial Rashes Case Studies – Practical Guide to Assessment and Management

Dr Rupert Hinds

Dr Rupert Hinds

Abdominal Pain in Children – Practical Approach in GP

Prof Roger Chen

Prof Roger Chen

Practical Guide to Improving Control of T2D

A/Prof Debbie Rigby

A/Prof Debbie Rigby

Why Inhaler Device Design and Technique Matters

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Tune in for "Gallbladder – When surgery is or is not needed" lecture

Tuesday 26th May, 7pm - 9pm AEST

Speaker

Dr David Yeo

Specialist Upper GI, Hepatobiliary and Bariatric Surgeon; Chris O’Brien Lifehouse, RPA and St George Hospitals

In this talk, surgeon, Dr David Yeo will answer these and many other real-world questions related to this common condition and provide an update on the latest recommendations for the assessment, investigation and management of gallbladder disease.